Michael P. Caligiuri

Prof. Michael P. Caligiuri


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2000 in Journal of Affective Disorders
Verified
Journal Article
Closed access
MCMichael P. Caligiuri
Michael P. Caligiuri
JEJoel Ellwanger
Joel Ellwanger

1 July 2003 in Psychiatry Research: Neuroimaging
Verified
Journal Article
Closed access
MCMichael P. Caligiuri
Michael P. Caligiuri
GBGregory G Brown
Gregory G Brown
MMM.J Meloy
M.J Meloy
SESonja C Eberson
Sonja C Eberson
SKSandra S Kindermann
Sandra S Kindermann
JLJames B Lohr
James B Lohr

1 November 2000 in Drugs & Aging
Verified
Journal Article
Closed access
PDF file
MCMichael P. Caligiuri
Michael P. Caligiuri
DJDilip V. Jeste
Dilip V. Jeste
JLJonathan P. Lacro
Jonathan P. Lacro

1 October 2006 in Human Movement Science
Verified
Journal Article
Closed access
MCMichael P. Caligiuri
Michael P. Caligiuri
HTHans-Leo Teulings
Hans-Leo Teulings
JFJ. Vincent Filoteo
J. Vincent Filoteo
DSDavid Song
David Song
JLJames B. Lohr
James B. Lohr

1 May 2010 in Psychiatry Research
Verified
Journal Article
Closed access
MCMichael P. Caligiuri
Michael P. Caligiuri
HTHans-Leo Teulings
Hans-Leo Teulings
CDCharles E. Dean
Charles E. Dean
ANAlexander B. Niculescu
Alexander B. Niculescu
JLJames B. Lohr
James B. Lohr

1 August 1999 in Journal of Clinical Psychopharmacology
Verified
Journal Article
Closed access
MCMichael P. Caligiuri
Michael P. Caligiuri
JLJonathan P. Lacro
Jonathan P. Lacro
DJDilip V. Jeste
Dilip V. Jeste
The available literature suggests that a sizable proportion of patients placed on neuroleptics develop acute and subacute extrapyramidal side effects, including neuroleptic-induced parkinsonism (NIP). The presence of mild, spontaneous extrapyramidal signs in the elderly makes it difficult to accurately estimate the incidence of NIP in this subgroup of patients. We examined the incidence of NIP in 56 older, newly medicated, psychiatric patients. Fifteen age-comparable, unmedicated psychiatric patients underwent 2 assessments to estimate natural fluctuation in extrapyramidal signs, and 49 normal, healthy, elderly individuals were also studied to establish age-comparable norms for the assessment of parkinsonism. Potential pretreatment predictor variables included instrumental measures of motor function, age, cognitive status, and psychiatric diagnosis. After controlling for spontaneous parkinsonism, 32% of patients met strict criteria for NIP after receiving an average of 43 mg/day chlorpromazine equivalents of a typical neuroleptic. Factors contributing to the development of NIP included older age, instrumentally derived tremor, baseline extrapyramidal signs, type of neuroleptic, and severity of dementia. The use of risperidone in a small subsample was not associated with NIP. These findings indicate that even after controlling for spontaneous extrapyramidal signs at baseline and their natural fluctuations, there is a substantial risk of NIP in older patients who are treated with very low doses of typical neuroleptics. (J Clin Psychopharmacol 1999;19:322-328)